Zosano Pharma (NASDAQ: ZSAN) disclosed in a proxy filing that it is seeking shareholder approval for a reverse stock split.From ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE